12/21
Headlines

DVAX

Hot Stock List: Bristol-Myers Squibb Company (NYSE:BMY), SunEdison, Inc. (NYSE:SUNE), Fairway Group Holdings Corp. (NASDAQ:FWM), Celgene Corporation (NASDAQ:CELG), Dynavax Technologies Corporation (NASDAQ:DVAX)

Jayne Crisman03 mins

Bristol-Myers Squibb Company (NYSE:BMY) has signed an option agreement to acquire Galecto Biotech of Denmark and get access to its early-stage investigational idiopathic pulmonary fibrosis treatment. Bristol-Myers Squibb Company (NYSE:BMY) belongs to Healthcare sector. Its net profit margin is 16.90% and weekly performance is 7.98%. On last trading day company shares ended up $57.80. Bristol-Myers…

Read More

Trader’s Recap : Dynavax Technologies Corporation (NASDAQ:DVAX), EOG Resources, Inc. (NYSE:EOG), Navios Maritime Partners L.P. (NYSE:NMM), Monsanto Company (NYSE:MON), SPX Corporation (NYSE:SPW)

Chris Lewis02 mins

On Oct 07, Dynavax Technologies Corporation (NASDAQ:DVAX) announced that Dino Dina, M.D, has resigned from the Board of Directors. Dr. Dina was a director of the Company since 1997 and was the Company’s Chief Executive Officer between 1998 and 2013. Dynavax Technologies Corporation (NASDAQ:DVAX) belongs to Healthcare sector. Its weekly performance is 2.68%. On last…

Read More

NASDAQ Bullish Stocks: Ctrip.com International (NASDAQ:CTRP), Celldex Therapeutics (NASDAQ:CLDX), Dynavax Technologies Corporation (NASDAQ:DVAX), JA Solar Holdings (NASDAQ:JASO)

Kevin Long02 mins

TheStreet has updated their ratings on a number of other stocks in the last week. The firm downgraded shares of Ctrip.com International, Ltd. (ADR) (NASDAQ:CTRP) from a buy rating to a hold rating. Ctrip.com International, Ltd. (ADR) (NASDAQ:CTRP) stock performance was 9.25% in last session and finished the day at $49.48. Traded volume was 4.31million…

Read More

Drug Stocks In News: Teva Pharmaceutical Industries (NYSE:TEVA), Allergan (NYSE:AGN), Dynavax Technologies Corporation (NASDAQ:DVAX), ISIS Pharmaceuticals (NASDAQ:ISIS)

Kevin Long02 mins

Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) announces the launch of the generic equivalent to Lunesta(R) (Eszopiclone Tablets, CIV), 1, 2 and 3 mg, in the United States. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock performance was -0.68% in last session and finished the day at $49.61. Traded volume was 2,806.00million shares in the last session…

Read More